The Drosophila microRNA mir-14 suppresses cell death and is required for normal fat metabolism
The comparison between injectable versus oral peptide delivery explains the pharmacokinetic differences between these routes
By inhibiting glucagon, GLP-1 prevents the liver from releasing too much glucose into the bloodstream, helping to keep blood sugar levels under control
In addition, GLP-1 contributes to weight loss, primarily through mechanisms such as appetite suppression, reduced food intake, and delayed gastric emptying [44]
Other investigated covariates (sex, race, ethnicity, age group, hepatic impairment) were not found to be influential and were not included in the final model
Alexander-Miller, M